Literature DB >> 22149817

Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process.

David J Carlson1, Kamil M Yenice, Colin G Orton.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22149817     DOI： 10.1118/1.3639137

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  10 in total

Review 1.  Molecular imaging of tumor hypoxia with positron emission tomography.

Authors:  Olivia J Kelada; David J Carlson
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

Review 2.  The Reciprocity between Radiotherapy and Cancer Immunotherapy.

Authors:  Yifan Wang; Zhi-Gang Liu; Hengfeng Yuan; Weiye Deng; Jing Li; Yuhui Huang; Betty Y S Kim; Michael D Story; Wen Jiang
Journal:  Clin Cancer Res       Date:  2018-11-09       Impact factor: 12.531

3.  Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Authors:  Wen-Jing Yin; Dong-Ping Chen; Meng-Yao Wang; Lu Zheng; En-Lai Dong; Jin-Quan Liu; Bin Qi
Journal:  Ann Transl Med       Date:  2021-08

4.  Preliminary studies with a new hypoxia-selective cytotoxin, KS119W, in vitro and in vivo.

Authors:  Eugene Y Kim; Yanfeng Liu; Oluwatoyin M Akintujoye; Krishnamurthy Shyam; Tina A Grove; Alan C Sartorelli; Sara Rockwell
Journal:  Radiat Res       Date:  2012-08-03       Impact factor: 2.841

5.  Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition.

Authors:  Ya-Guang Li; Nai-Xin Liang; Ying-Zhi Qin; Dong-Jie Ma; Chang-Jin Huang; Lei Liu; Shan-Qing Li
Journal:  Tumour Biol       Date:  2016-11-30

Review 6.  Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.

Authors:  Noel E Donlon; Robert Power; Conall Hayes; Maria Davern; John V Reynolds; Joanne Lysaght
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

7.  Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.

Authors:  Stewart Mein; Thomas Tessonnier; Benedikt Kopp; Semi Harrabi; Amir Abdollahi; Jürgen Debus; Thomas Haberer; Andrea Mairani
Journal:  Adv Radiat Oncol       Date:  2021-02-04

8.  Tumor-penetrating peptide internalizing RGD enhances radiotherapy efficacy through reducing tumor hypoxia.

Authors:  Fanyan Meng; Jun Liu; Jia Wei; Ju Yang; Chong Zhou; Jing Yan; Baorui Liu
Journal:  Cancer Sci       Date:  2022-03-11       Impact factor: 6.716

9.  Impact of pretreatment whole-tumor perfusion computed tomography and 18F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy.

Authors:  Masahiko Aoki; Hiroyoshi Akimoto; Mariko Sato; Katsumi Hirose; Hideo Kawaguchi; Yoshiomi Hatayama; Hiroko Seino; Shinya Kakehata; Fumiyasu Tsushima; Hiromasa Fujita; Tamaki Fujita; Ichitaro Fujioka; Mitsuki Tanaka; Hiroyuki Miura; Shuichi Ono; Yoshihiro Takai
Journal:  J Radiat Res       Date:  2016-06-13       Impact factor: 2.724

10.  Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.

Authors:  Chun-Chia Cheng; Siao-Syun Guan; Hao-Jhih Yang; Chun-Chao Chang; Tsai-Yueh Luo; Jungshan Chang; Ai-Sheng Ho
Journal:  J Biomed Sci       Date:  2016-01-28       Impact factor: 8.410
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.